Nordson today announced it signed an agreement to acquire medical infusion fluid delivery tech developer Atrion Corp. for nearly $800 million. The agreement includes $460 per share in cash to reflect a valuation of 15 times Atrion’s 2024 full-year estimated EBITDA, including synergies Nordson expects to generate in its first two years of owning Atrion. […]
